D.C. Federal Judge Finds FDA Did Not Violate Law In Approving Generic Drug

( February 19, 2025, 1:40 PM EST) -- WASHINGTON, D.C. — A federal judge in the District of Columbia was unconvinced that the U.S. Food and Drug Administration violated the Administrative Procedure Act (APA) when it granted approval to a generic drug, denying a motion for summary judgment filed by a drug manufacturer and granting cross-motions filed by the FDA and the generic drug maker....